Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
As has become tradition in the pharma and biotech world, 2024 kicked off with a bang as experts from around the globe gathered in San Francisco for the 42nd annual JP Morgan Health Conferen
The story of CRISPR’s development, from its humble beginnings as a bacterial defence mechanism to its current status as a groundbreaking tool for gene editing and beyond, is a fascinating j
Sustainability has become a crucial pillar in pharmaceutical development, with environmental concerns and resource management demanding immediate attention from organisations of all sizes a
Behind every successfully approved treatment lies a nexus of clinical research activities comprising myriad drug types, trial phases, and packaging needs across diverse geographical locatio
Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.